3005B |
Methylchloroform Exposure, Blood |
3005SP |
Methylchloroform Exposure, Serum/Plasma |
3006U |
Methylchloroform, Urine |
3061B |
Milnacipran/Levomilnacipran, Blood |
3061SP |
Milnacipran/Levomilnacipran, Serum/Plasma |
3061U |
Milnacipran/Levomilnacipran, Urine |
3075B |
Mirtazapine, Blood |
3075SP |
Mirtazapine, Serum/Plasma |
3075U |
Mirtazapine, Urine |
3145B |
Nefazodone, Blood |
3145SP |
Nefazodone, Serum/Plasma |
3145U |
Nefazodone, Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3220B |
Nortriptyline, Blood |
3220SP |
Nortriptyline, Serum/Plasma |
3220TI |
Nortriptyline, Tissue |
3220U |
Nortriptyline, Urine |
3225SP |
Nuedexta®, Serum/Plasma |
3250SP |
Oxalate, Serum/Plasma |
3360B |
Paroxetine, Blood |
3360FL |
Paroxetine, Fluid |
3360SP |
Paroxetine, Serum/Plasma |
3360TI |
Paroxetine, Tissue |
3360U |
Paroxetine, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3430B |
Tetrachloroethylene, Blood |
3432U |
Perchloroethylene Exposure, Urine |
3550B |
Phenelzine, Blood |
3550SP |
Phenelzine, Serum/Plasma |
3550U |
Phenelzine, Urine |
3621B |
Phenol - Free and Total, Blood |
3621SP |
Phenol - Free and Total, Serum/Plasma |
3621U |
Phenol Exposure, Urine |
3623B |
Phenol, Free, Blood |
3623SP |
Phenol, Free, Serum/Plasma |
3624B |
Phenol, Total, Blood |
3974B |
Propane, Blood |
3974TI |
Propane, Tissue |